Rep. Kevin Hern (R-OK) Sells MRSH Stock
Oklahoma Congressman Kevin Hern has sold shares of Marsh & McLennan valued between $100,001 and $250,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Kevin Hern (R-OK) sold between $100,001 and $250,000 of Marsh & McLennan Companies, Inc. ($MRSH) stock on September 9, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed September 25, 2026.
Since the trade, $MRSH is down 0.0% after 1 week, down 0.0% after 1 month and up 7.1% to date (from the $175.81 close on Sep 9, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Kevin Hern (R-OK)
- Status:
- Member — House
- State/District:
- OK-1
- Party:
- Republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Sep 25, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Marsh & McLennan Companies, Inc. ($MRSH) | Sell | Sep 9, 2026 | $100,001 - $250,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
MRSH
Marsh & McLennan Companies, Inc.
Key Points
- Kevin Hern sold shares of Marsh & McLennan Companies, Inc. valued between $100,001 and $250,000 on September 9, 2026.
- The stock was trading around $188.36 at the time of the sale, above its 50-day moving average of $185.51.
- Marsh & McLennan has a market cap of about $82.4 billion and a forward P/E ratio of 15.1.
Get $MRSH trade alerts by text
We text you when insiders, Congress or big funds trade $MRSH. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Marsh & McLennan Companies, Inc. alert may contain errors. Disclosures
Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan Companies, Inc. (MRSH) on September 9, 2026. The transaction was valued between $100,001 and $250,000, according to his report filed under the STOCK Act on September 25, 2026.
Kevin Hern vs. the S&P 500
Hypothetical returns from Kevin Hern's disclosed trades, not real profit or advice. How we model this.
Inside Kevin Hern's Trade
Hern's sale comes at a time when the stock is trading at approximately $188.36. This value is notably higher than its previous close of $175.01. His stake in Marsh & McLennan reflects his ongoing engagement with this financial services company, which provides advisory services and insurance solutions.
Other Institutional Activity in Marsh & McLennan
Blackrock Inc. decreased its stake in Marsh & McLennan, selling 2,561,681 shares and bringing its total to about 39.5 million shares worth approximately $7.41 billion. Vanguard Capital Management LLC slightly increased its position, adding 6,293 shares for a total of 31.5 million shares valued at about $5.9 billion. Meanwhile, State Street Corporation added 331,059 shares, raising its holdings to around 22.4 million shares worth about $4.20 billion.
Marsh & McLennan Companies, Inc. Stock Up 1.0%
The shares of Marsh & McLennan are currently trading close to their recent highs and well above the 52-week low of $156.60. As of today, the stock is showing a stable trading pattern, maintaining levels above its 50-day moving average of $185.51, which indicates a positive trend.
Recent Earnings
In its latest quarter, Marsh & McLennan reported revenues of approximately $27.9 billion, representing a 6.2% increase year-over-year. The company's earnings per share stood at $8.19, with a net margin of 14.2%. The next earnings report is scheduled for October 15, 2026.
Analysts Set New Price Targets
Analysts have varied opinions on Marsh & McLennan, with Wells Fargo maintaining an Equal-Weight rating and a price target of $197 on October 16, 2026. UBS currently has a Buy rating with a price target of $222, reflecting significant potential upside. The consensus recommendation across 21 analyst opinions is to hold.
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies, Inc. is a professional services firm based in New York that offers risk management, insurance broking, and consulting services globally. Their expertise in advisory services makes them a key player in the financial services sector, particularly valuable for Congressman Hern's constituents who may rely on their services for comprehensive insurance solutions.
Bottom Line
As Kevin Hern continues to adjust his investment portfolio, attention will be on Marsh & McLennan's upcoming earnings report on October 15, 2026. The recent stock activity and the 13F filings provide insight into institutional interests, but they only reflect past holdings and may not represent current positions.
Related Filing Alerts
Source: Kevin Hern's STOCK Act disclosure on $MRSH (Sep 9, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts